Voya Financial Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,650
Closed -$282K 224
2025
Q2
$282K Sell
2,650
-829
-24% -$83.9K 0.03% 200
2025
Q1
$346K Sell
3,479
-208
-6% -$20.9K 0.04% 171
2024
Q4
$331K Buy
3,687
+427
+13% +$37.6K 0.04% 185
2024
Q3
$272K Sell
3,260
-230
-7% -$18.1K 0.03% 199
2024
Q2
$269K Sell
3,490
-405
-10% -$29.6K 0.03% 205
2024
Q1
$267K Sell
3,895
-269
-6% -$17.3K 0.03% 206
2023
Q4
$234K Sell
4,164
-89
-2% -$4.75K 0.03% 213
2023
Q3
$227K Sell
4,253
-58
-1% -$3.04K 0.03% 207
2023
Q2
$230K Buy
4,311
+99
+2% +$5.17K 0.03% 212
2023
Q1
$209K Buy
+4,212
New +$199K 0.03% 219

Other funds holding BSX

Voya Financial Advisors's BSX Position: Q3 2025 in Review

Voya Financial Advisors sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 2,650 shares — an estimated $282K sold.

Voya Financial Advisors first reported a position in BSX in Q1 2023 and held it in 10 quarters. The position peaked at $346K in Q1 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Voya Financial Advisors reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Voya Financial Advisors sold 2,650 Boston Scientific shares in Q3 2025, an estimated $282K.
  • Voya Financial Advisors first reported a position in Boston Scientific in Q1 2023 and held it in 10 quarters.
  • Voya Financial Advisors's Boston Scientific position peaked at $346K in Q1 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Voya Financial Advisors's 13F filing for Q3 2025, filed 9 Oct 2025.